HEPATITIS FULMINANT

This adverse event was reported 2970 times

HEPATITIS FULMINANT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 MOXIDECTIN 1 0.3333
1 METHYL SULFONYL METHANE 1 0.2000
2 DOXAPRAM HYDROCHLORIDE 3 0.1364
3 GLYCERIN BASED GENTLE AND EFFECTIVE LAXATIVE ADULT CONSTIPATION RELIEF 1 0.1250
4 AMPICILLIN SODIUM, SULBACTAM SODIUM 2 0.0526
5 BICISATE DIHYDROCHLORIDE 1 0.0435
6 DICLOFENAC SODIUM/MISOPROSTOL 3 0.0068
7 ERYTHROMYCIN LACTOBIONATE 1 0.0068
8 QUAZEPAM 2 0.0066
9 TOLCAPONE 2 0.0057
See all drugs enriched for association with HEPATITIS FULMINANT

HEPATITIS FULMINANT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Antimycobacterial [EPC] 74 0.0030
1 Aldehyde Dehydrogenase Inhibitor [EPC] 3 0.0026
2 Lymphocyte Growth Factor [EPC] 3 0.0024
3 Tricyclic Antidepressant [EPC] 1 0.0021
4 CD38-directed Cytolytic Antibody [EPC] 12 0.0021
5 CD33-directed Immunoconjugate [EPC] 7 0.0019
6 Penem Antibacterial [EPC] 58 0.0017
7 Glinide [EPC] 14 0.0016
8 Sulfone [EPC] 17 0.0016
9 Monobactam Antibacterial [EPC] 4 0.0015
See all drug classes enriched for association with HEPATITIS FULMINANT